Sector News

EMA chief Rasi kicked out as tribunal annuls appointment

November 14, 2014
Life sciences
The European Medicines Agency’s executive director Guido Rasi has been forced to step down after his appointment, made three years, was annulled by a EU panel.
 
The European Union Civil Service Tribunal has ruled on an appeal by an individual against the selection procedure in 2011 for the appointment of executive director of the EMA. The unnamed person brought the case in January 2012 following the decision by the European Commission not to include him on the shortlist of candidates.
 
The court has, “on purely formal grounds”, annulled the Commission’s decision of adopting a shortlist and as a consequence, the choice of Dr Rasi (pictured) has also been annulled.
 
Sir Kent Woods, chair of the EMA management board, noted “with regret” the tribunal’s judgement, saying “it is important to remember that the ruling is about a procedural formality. It is not a reflection on Guido Rasi’s competence or ability to run the agency, something which he has done successfully since November 2011.”
 
The European Commission and EMA are both taking legal advice. “Pending further decisions”, Andreas Pott, the agency’s deputy executive director, will take over.
 
By Kevin Grogan
 
Source: Pharma Times
 

Related News

April 10, 2021

Genentech aims high with new diversity goals, including doubling hires and spending $1B with diverse suppliers

Life sciences

Quita Highsmith, Genentech’s chief diversity officer, is helping the pharma double down on diversity and inclusion goals with a new 2025 plan. 

April 10, 2021

Merck CEO Frazier joins army of Black execs speaking out on restrictive voting-rights laws

Life sciences

Merck CEO Kenneth Frazier teamed up with former American Express executive Kenneth Chenault to protest a voting-rights law passed recently in Georgia.

April 10, 2021

Zimmer Biomet bundles robotic surgery, apps and digital health programs into one orthopedics package

Life sciences

By bringing together big data and robotic procedures, the ultimate goal of the connected suite is to take some of the guesswork out of orthopedic medicine. 

Send this to a friend